Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$522.38 +6.04 (+1.17%)
At close: Sep 24, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Price to Earnings (2009 - 2026)

Vertex Pharmaceuticals (VRTX) posted Price to Earnings of 114.43 for Q2 2026, up 3.99% on a QoQ basis from 110.04 in Q1 2026, and up 3.58% year-over-year from 110.47 in Q2 2025.

Analysis

Vertex Pharmaceuticals (VRTX) Price to Earnings (2009 - 2026) Analysis & Trends

Vertex Pharmaceuticals has reported Price to Earnings for 18 years, with the latest figure at 114.43 in Q2 2026.

  • On a quarterly basis, Price to Earnings rose 3.58% year-over-year to 114.43 in Q2 2026; TTM through Jun 2026 was 28.57, a 8.93% decrease from a year earlier, with the FY2025 full-year figure at 29.13, up 115.08% from the prior year.
  • Price to Earnings was 114.43 for Q2 2026 at Vertex Pharmaceuticals, up from 110.04 in the prior quarter.
  • The five-year high for Price to Earnings was 192.76 in Q1 2025, with the low at 33.65 in Q2 2024.
  • Average Price to Earnings over 5 years is 98.09, with a median of 98.63 recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Price to Earnings plunged 133.97% in 2024, then soared 428.25% in 2025.
  • Over 5 years, Price to Earnings stood at 90.63 in 2022, then grew by 19.42% to 108.23 in 2023, then advanced by 4.71% to 113.33 in 2024, then fell by 14.7% to 96.67 in 2025, then increased by 18.36% to 114.43 in 2026.
  • The last three Price to Earnings figures came in at 114.43 (Q2 2026), 110.04 (Q1 2026), and 96.67 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 114.43
Mar 31, 2026 110.04
Dec 31, 2025 96.67
Sep 30, 2025 91.84
Jun 30, 2025 110.47
Mar 31, 2025 192.76
Dec 31, 2024 113.33
Sep 30, 2024 114.66
Jun 30, 2024 -33.65
Mar 31, 2024 98.19
Dec 31, 2023 108.23
Sep 30, 2023 86.60
Jun 30, 2023 99.07
Mar 31, 2023 115.94
Dec 31, 2022 90.63
Sep 30, 2022 79.86
Jun 30, 2022 89.01
Mar 31, 2022 87.52
Dec 31, 2021 72.57
Sep 30, 2021 54.55
API Access

Vertex Pharmaceuticals Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=VRTX&period=max&api_key=YOUR_API_KEY